|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/5375 | |
| A61K 31/137 | |||
| A61P 25/24 | |||
| A61P 25/34 | |||
| A61P 25/20 |
| (11) | Patento numeris | 1602369 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05106426.9 |
| Europos patento paraiškos padavimo data | 2000-08-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-12-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-04-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 510241 | 2000-02-22 | US | |
| 640725 | 2000-08-18 | US |
| (72) |
Fang, Qun, K, US
Senanayake, Chrisantha, H, US
Grover, Paul, US
|
| (73) |
SEPRACOR, INC.,
84 Waterford Drive, Marlborough, MA 01752,
US
|
| (54) | Bupropion Metabolites for treating anxiety |
| Bupropion Metabolites for treating anxiety |